グルタミン阻害は,腫瘍の免疫回避を克服するために,異なった代謝プログラムを誘導する
Robert D Leone1, Liang Zhao1, Judson M Englert1
1The Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.
まとめ
ガン細胞の代謝をグルタミン抗剤で標的化すると 腫瘍の微小環境が再構成されます このアプローチはエフェクターT細胞の機能を強化し,がん免疫療法の新しい代謝チェックポイント戦略を提供します.
科学分野:
- 癌 生物学
- 免疫学
- 代謝経路
背景:
- 腫瘍の代謝特性により,免疫細胞の機能と癌の免疫療法が妨げられます.
- 腫瘍の微小環境はしばしば代謝因子による免疫抑制作用がある.
研究 の 目的:
- 腫瘍の微小環境と免疫細胞に対するグルタミン抗体の影響を調査する.
- ガン免疫療法における代謝障害を克服する戦略としてグルタミン抗作用を研究する.
主な方法:
- 腫瘍を患ったマウスで グルタミン抗体を投与した.
- 癌細胞とエフェクターT細胞の代謝プロファイルを分析した.
- 腫瘍の低酸素症,酸性症,栄養レベルの変化を評価した.
主要な成果:
- グルタミン阻害は,がん細胞の酸化と糖分分解の代謝を抑制した.
- 腫瘍の低酸素症,酸性症,栄養素の減少が観察されました.
- エフェクターT細胞は酸化代謝を向上させ,活性化と長寿を高めました.
結論:
- 腫瘍の微小環境を代謝的に再構成し,免疫抑制を減少させます.
- ガン細胞とT細胞の 異なった代謝再プログラムが 抗腫瘍反応を引き起こします
- この代謝的可塑性をグルタミン抗作用で利用することは,がん免疫療法における有望な"代謝のチェックポイント"です.
さらに関連する動画
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
16.4K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.6K
関連する概念動画
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Adaptive Mechanisms in Cancer Cells
6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
